Lotiglipron

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C31H31ClN4O5
Molecular Weight	575.055
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@]1(OC2=CC=CC(C3CCN(CC4=NC5=C(C=C(C=C5)C(O)=O)N4C[C@@H]6CCO6)CC3)=C2O1)C7=CC=C(Cl)C=N7

InChI

InChIKey=SVPYZAJTWFQTSM-UGDMGKLASA-N

InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38)/t22-,31-/m0/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Lotiglipron

Official Name

English

PF-07081532

Preferred Name

English

LOTIGLIPRON [USAN]

Common Name

English

1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2S)-2-(5-chloro-2-pyridinyl)-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]-

Systematic Name

English

2-({4-[(S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[1,3]dioxol-4-yl]piperidin-1-yl}methyl)-1-{[(S)-oxetan-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid

Systematic Name

English

lotiglipron [INN]

Common Name

English

Code System Code Type Description

FDA UNII

YI10W1K93A